Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | Genomic profiling SMM

Mark Bustoros • 13 Sep 2019
IMW 2019
Multiple Myeloma Rare Diseases Smoldering Myeloma

Mark Bustoros, MD, Dana-Farber Cancer Institute, Boston, MA, interviews with VJHemOnc at the International Myeloma Workshop (IMW) 2019, held in Boston, MA, and discusses how the genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression.

More from Mark Bustoros

3:23
Molecular characteristics associated with increased risk of disease progression in SMM
Mark Bustoros • 27 Sep 2023
2:25
Biomarkers of progression and risk stratification in asymptomatic Waldenström's macroglobulinemia
Mark Bustoros • 27 Sep 2023
1:11
Advances that have been made in the molecular characterization of multiple myeloma
Mark Bustoros • 27 Sep 2023
1:50
Molecular characteristics of extramedullary myeloma
Mark Bustoros • 27 Sep 2023

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals